Safety of reduced-antigen-content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis–containing vaccine

F Zepp, M Knuf, P Habermehl… - The Journal of …, 2006 - Elsevier
OBJECTIVE: The safety of a booster dose of a reduced-antigen-content tetanus–diphtheria–
acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with …

Immunogenicity of reduced antigen content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing …

F Zepp, P Habermehl, M Knuf, W Mannhardt-Laakman… - Vaccine, 2007 - Elsevier
Three hundred and nineteen adolescents aged 10–12 years who had been previously
vaccinated with five doses of acellular pertussis-containing vaccines received single doses …

Reactogenicity of tetanus, diphtheria, 5-component acellular pertussis vaccine administered as a sixth consecutive acellular pertussis vaccine dose to adolescents

JG Liese, N Rieber, T Malzer, M Ocak… - The Pediatric …, 2010 - journals.lww.com
Background: Safety of a sixth consecutive dose of acellular pertussis vaccine in adolescents
was assessed in a 2-armed, randomized study. Methods: Adolescents who had received 5 …

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children

ME Pichichero, MA Deloria, MB Rennels… - …, 1997 - publications.aap.org
Objective. To compare the safety and immunogenicity of 12 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults

SA Halperin, B Smith, M Russell, P Hasselback… - Vaccine, 2000 - Elsevier
Pertussis is increasingly being recognized as an important cause of cough illness in
adolescents and adults. To evaluate the safety and immunogenicity of an adult formulation …

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children

ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …

Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with …

R Dagan, K Igbaria, L Piglansky, F Van Brusteghem… - Vaccine, 1999 - Elsevier
Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …

Extensive swelling after booster doses of acellular pertussis–tetanus–diphtheria vaccines

MB Rennels, MA Deloria, ME Pichichero… - …, 2000 - publications.aap.org
Background. Diphtheria and tetanus toxoid combined with acellular pertussis (DTaP)
vaccines are less reactogenic than diphtheria and tetanus toxoid combined with whole cell …

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

SA Halperin, L Sweet, D Baxendale… - The Pediatric …, 2006 - journals.lww.com
Background: Adult formulation tetanus and diphtheria toxoids and acellular pertussis
vaccines (Tdap) have been developed to prevent pertussis in adolescents and adults. There …

Comparison of diphtheria-tetanus-two component acellular pertussis vaccines in United States and Japanese infants at 2, 4, and 6 months of age

EP Rothstein, H Kamiya, R Nii, T Matsuda… - …, 1996 - publications.aap.org
Objective. We compared the diphtheria and tetanus toxoids and bicomponent acellular
pertussis vaccine (DTaP) responses in Japanese and United States infants. Design. This …